Food increases the bioavailability of tolterodine but not effective exposure.
- 8 March 2001
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (3) , 298-304
- https://doi.org/10.1177/00912700122010113
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activityPublished by Wiley ,1999
- Antimuscarinic Potency and Bladder Selectivity of PNU‐200577, a Major Metabolite of TolterodineBasic & Clinical Pharmacology & Toxicology, 1997
- Individual Variation in First-Pass MetabolismClinical Pharmacokinetics, 1993
- A computer simulation of the food effect: Transient changes in hepatic blood flow and michaelis‐menten parameters as mediators of hepatic first pass metabolism and bioavailability of propranololBiopharmaceutics & Drug Disposition, 1990
- Food increases the bioavailability of propafenone.British Journal of Clinical Pharmacology, 1987
- Interactions Affecting Drug AbsorptionClinical Pharmacokinetics, 1984
- Influence of Food Intake on Presystemic Clearance of DrugsClinical Pharmacokinetics, 1983
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detectionJournal of Chromatography A, 1977
- Pharmacokinetic Properties of the ??-Adrenergic Receptor Blocking DrugsDrugs, 1974